May 30, 2023 / 04:30PM GMT
Tyler Martin Van Buren - TD Cowen, Research Division - MD & Senior Equity Research Analyst
All right. We'll give it a couple of seconds for everyone to join. Okay. So with that, welcome, everyone, again, to the TD Cowen's Fourth Annual Oncology Innovation Summit: Highlights for ASCO and EHA. My name is Tyler Van Buren, senior biotech analyst here at TD Cowen. For our next session, we're very pleased to have a fireside chat with Regeneron. And it's my sincere pleasure to introduce Izzy Lowy, Senior Vice President of Solid Organ Oncology Development; and Andreas Sirulnik, Senior Vice President of Heme-Onc Development. Izzy and Andreas, it's a privilege to have you both here. Thank you very much for joining me.
L. Andres Sirulnik - Regeneron Pharmaceuticals, Inc. - SVP of Translational & Clinical Sciences, Hematology
Thank you for having us, Tyler.
Tyler Martin Van Buren - TD Cowen, Research Division - MD & Senior Equity Research Analyst
Ryan, Head of IR -- Ryan Crowe, Head of IR, thank you very much for being
Regeneron Pharmaceuticals Inc at TD Cowen Oncology Innovation Summit (Virtual) Transcript
May 30, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers